News | May 03, 2023
CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
This acquisition will boost Neogen's portfolio by offering organolithium derivatives to existing pharma industry
The WHO - Global Center for Traditional Medicine will help member countries in taking enabling steps in their countries for strengthen education and practices of traditional mdicine
The company expects the GMP approval from Saudi Food and Drug Authority (SFDA) to soon pave the way for marketing authorizations from the largest market in the GCC region
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
IAGES to focus on upskilling and adoption of advanced Minimal Access Surgery technologies in 2023
With the new facility, the company underlines its commitment to meet the substantially growing demand for its MCC
Subscribe To Our Newsletter & Stay Updated
